Orum Therapeutics, Inc. (KOSDAQ:475830)
82,200
+500 (0.61%)
At close: Dec 5, 2025
Orum Therapeutics Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Cash & Equivalents | 15,533 | 19,700 | 126,658 | 11,276 |
| Short-Term Investments | 128,130 | 99,099 | - | - |
| Trading Asset Securities | - | - | - | 809.55 |
| Cash & Short-Term Investments | 143,664 | 118,799 | 126,658 | 12,085 |
| Cash Growth | 15.69% | -6.21% | 948.05% | - |
| Accounts Receivable | 9.89 | 2.48 | 0.6 | - |
| Other Receivables | 256.88 | 2,530 | 492.53 | 38.37 |
| Receivables | 266.77 | 2,532 | 493.14 | 38.37 |
| Prepaid Expenses | 5,171 | 966.55 | 254.5 | 460.26 |
| Other Current Assets | 582.09 | 212.88 | 41.83 | 72.42 |
| Total Current Assets | 149,684 | 122,510 | 127,448 | 12,656 |
| Property, Plant & Equipment | 30,943 | 30,610 | 32,370 | 5,184 |
| Long-Term Investments | 42.07 | 44.1 | 12.87 | 2,552 |
| Long-Term Deferred Tax Assets | 569.54 | 597.08 | 974.69 | 543.48 |
| Other Long-Term Assets | 1,092 | 74.48 | 977.7 | 346.91 |
| Total Assets | 182,330 | 153,836 | 161,783 | 21,283 |
| Accounts Payable | - | - | 3.45 | 839.48 |
| Accrued Expenses | 2,324 | 2,079 | 5,138 | 4,932 |
| Short-Term Debt | - | - | - | 208.32 |
| Current Portion of Leases | 2,578 | 28,122 | 2,572 | 845.64 |
| Current Income Taxes Payable | - | - | 217.72 | 462.26 |
| Other Current Liabilities | 9,603 | 1,663 | 1,207 | 1,633 |
| Total Current Liabilities | 14,505 | 31,864 | 9,137 | 8,920 |
| Long-Term Debt | - | - | - | 937.44 |
| Long-Term Leases | 22,539 | 207.75 | 23,308 | 597.78 |
| Other Long-Term Liabilities | 101.19 | 0 | 138.26 | 136.6 |
| Total Liabilities | 37,145 | 32,071 | 32,583 | 10,592 |
| Common Stock | 2,116 | 1,843 | 460 | 115 |
| Additional Paid-In Capital | 99,457 | 179,471 | 690 | 1,035 |
| Retained Earnings | 34,193 | -69,813 | -64,072 | -132,290 |
| Comprehensive Income & Other | 9,419 | 10,263 | 6,743 | 3,678 |
| Total Common Equity | 145,185 | 121,765 | -56,180 | -127,461 |
| Shareholders' Equity | 145,185 | 121,765 | 129,200 | 10,691 |
| Total Liabilities & Equity | 182,330 | 153,836 | 161,783 | 21,283 |
| Total Debt | 25,117 | 28,330 | 25,879 | 2,589 |
| Net Cash (Debt) | 118,546 | 90,469 | 100,779 | 9,496 |
| Net Cash Growth | 20.39% | -10.23% | 961.28% | - |
| Net Cash Per Share | 5894.54 | 4999.13 | 6693.64 | 2064.33 |
| Filing Date Shares Outstanding | 21.08 | 18.43 | 4.6 | 1.15 |
| Total Common Shares Outstanding | 21.08 | 18.43 | 4.6 | 1.15 |
| Working Capital | 135,179 | 90,647 | 118,310 | 3,736 |
| Book Value Per Share | 6885.97 | 6607.19 | -12212.99 | -110835.99 |
| Tangible Book Value | 145,185 | 121,765 | -56,180 | -127,461 |
| Tangible Book Value Per Share | 6885.97 | 6607.19 | -12212.99 | -110835.99 |
| Land | - | - | - | 1,591 |
| Machinery | 5,369 | 1,497 | 1,396 | 1,406 |
| Construction In Progress | - | 36 | - | 445.16 |
Source: S&P Capital IQ. Standard template. Financial Sources.